Table 1.

The biomarker concentrations according to the demographic and anthropometrical determinants in the study population.

Variables/Number of Patients (%)	YKL-40 Concentration (ng/mL)	TF Activity (pM)	Leptin Concentration (ng/mL)	hsAdiponectin Concentration (ng/mL)
81 (100%)	1.93 1.43/2.83	14.18 11.59/26.92	12.58 4.70/20.64	27.05 20.63/32.10
Age
<55 years	1.87	15.20	8.77	25.24
n = 41 (51%)	1.44/2.81	12.31/28.76	4.43/18.26	19.76/29.09
≥55 years	2.01	13.64	12.65	28.07
n = 40 (49%)	1.42/3.25	11.10/26.40	5.46/23.58	23.25/32.63
Menopausal status
Premenopausal	1.89	17.59	7.80	25.24
n = 27 (33%)	1.33/2.81	12.31/25.20	4.00/19.21	19.76/30.30
Postmenopausal	1.96	13.79	12.67	27.42
n = 54 (67%)	1.45/2.85	11.17/29.59	5.57/22.47	22.62/32.31
Body mass index			***	I vs. III *
18.5–24.9 kg/m2	1.91	16.29	5.30	28.19
n = 38 (47%)	1.36/2.85	11.77/29.59	3.12/11.56	23.88/33.63
25.0–29.9 kg/m2	1.85	14.01	14.31	27.02
n = 28 (35%)	1.43/2.54	11.73/25.38	8.70/21.63	19.28/32.12
30.0–39.9 kg/m2	2.35	15.20	25.72	24.44
n = 15 (18%)	1.78/2.90	9.02/38.2	16.92/40.85	16.93/27.91
Number of parity	II vs. III **II vs. IV *			II vs. IV *III vs. IV *
Nulliparous	2.24	13.21	10.29	23.55
n = 6 (7%)	1.42/2.83	11.62/21.31	5.57/31.39	20.51/34.83
1 child	2.53	17.41	13.06	27.81
n = 20 (25%)	2.02/2.93	9.53/36.63	6.33/23.02	24.20/32.97
2 children	1.64	14.99	12.63	27.47
n = 39 (48%)	1.33/2.57	12.31/25.88	3.73/19.40	20.64/33.27
3 children	1.78	13.70	12.38	24.44
n = 13 (16%)	1.35/2.35	11.47/33.47	3.78/23.60	18.29/27.37
4 children n = 1 (1%)	1.06	11.65	9.60	12.17
5 children	1.96	15.82	10.46	21.54
n= 2 (2%)	1.36/2.55	8.05/23.59	4.00/16.92	14.58/28.49

Abbreviations: Significant p-values are highlighted: * <0.01, ** <0.001, *** p < 0.0001; TF—tissue factor; hsAdiponectin—high sensitive adiponectin.